We are live on ! Find out more
Vanguard National Trust

Vanguard National Trust Portfolio holdings

AUM $1.84B
This Fund
S&P 500
This Quarter Est. Return
+13.63%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.84B
AUM Growth
+$248M
Cap. Flow
+$43.6M
Cap. Flow %
2.38%
Top 10 Hldgs %
65.04%
Holding
828
New
77
Increased
175
Reduced
119
Closed
41

Sector Composition

Rank Sector Weight
1 Technology 4.49%
2 Financials 2.85%
3 Healthcare 2.14%
4 Communication Services 1.27%
5 Consumer Staples 1.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYX icon
776
NCR Voyix
VYX
$1.13B
$376 ﹤0.01%
+46
New +$324
LUMN icon
777
Lumen
LUMN
$6.79B
$330 ﹤0.01%
+43
New +$377
GLIBK
778
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$1.02B
$302 ﹤0.01%
+14
New +$393
LILAK icon
779
Liberty Latin America Class C
LILAK
$1.65B
$273 ﹤0.01%
+35
New +$254
VGNT
780
Versigent PLC
VGNT
$3.27B
$210 ﹤0.01%
+5
New +$199
OGN icon
781
Organon & Co
OGN
$3.6B
$135 ﹤0.01%
10
-29
-74% -$347
PTNQ icon
782
Pacer Trendpilot 100 ETF
PTNQ
$1.27B
$89 ﹤0.01%
1
STRZ
783
Starz Entertainment Corp
STRZ
$445M
$87 ﹤0.01%
+3
New +$65
LILA icon
784
Liberty Latin America Class A
LILA
$1.69B
$86 ﹤0.01%
+11
New +$61
EPD icon
785
Enterprise Products Partners
EPD
$84B
$74 ﹤0.01%
2
GLIBA
786
Liberty Capital Corp Series A GCI Group Common Stock
GLIBA
$1.08B
$66 ﹤0.01%
+3
New +$85
FLNT
787
Fluent
FLNT
$129M
0
APPN icon
788
Appian
APPN
$2.5B
-116
Closed -$2.8K
ARES icon
789
Ares Management
ARES
$32.5B
-219
Closed -$23.9K
BEAM icon
790
Beam Therapeutics
BEAM
$2.8B
-33
Closed -$786
BNL icon
791
Broadstone Net Lease
BNL
$4.38B
-11,699
Closed -$214K
BYND icon
792
Beyond Meat
BYND
$200M
-1
Closed -$21
CGNX icon
793
Cognex
CGNX
$11B
-17
Closed -$833
CRL icon
794
Charles River Laboratories
CRL
$13.4B
-70
Closed -$12.1K
CRNC icon
795
Cerence
CRNC
$385M
-37
Closed -$233
CRSP icon
796
CRISPR Therapeutics
CRSP
$5.25B
-20
Closed -$951
CTRA
797
DELISTED
Coterra Energy
CTRA
-321
Closed -$11.3K
DNA icon
798
Ginkgo Bioworks
DNA
$466M
-10
Closed -$61
DOCU
799
DocuSign
DOCU
$11.8B
-44
Closed -$2.09K
DOV icon
800
Dover
DOV
$27.9B
-167
Closed -$34.8K

Similar funds

Vanguard National Trust's Q2 2026 Portfolio in Review

As of Q2 2026, Vanguard National Trust held 828 positions worth $1.84B, up 16% from $1.59B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Vanguard National Trust's Q2 2026 filing shows 77 new, 175 increased, 119 reduced and 41 closed positions. Its largest new stake was Vanguard Intermediate-Term Tax-Exempt Bond ETF: 13,606 shares worth $1.37M. The largest sale was Vanguard S&P 500 ETF, an estimated $4.55M.

By sector, the portfolio is most concentrated in Technology at 4.5% of assets, up from 4.2% a quarter earlier, followed by Financials and Healthcare.

  • Vanguard National Trust's largest Q2 2026 buy was Vanguard Intermediate-Term Tax-Exempt Bond ETF: 13,606 shares worth $1.37M.
  • Vanguard National Trust added most to Vanguard Morningstar Total Stock Market ETF in Q2 2026, an estimated $13.9M increase.
  • Vanguard National Trust's biggest Q2 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $4.55M.
  • Vanguard National Trust fully exited Broadstone Net Lease in Q2 2026, selling an estimated $214K.
  • Vanguard National Trust's ten largest holdings make up 65% of its $1.84B portfolio in Q2 2026.
  • Vanguard National Trust opened 77 new positions and closed 41 in Q2 2026.
  • Vanguard National Trust's portfolio value rose 16% quarter-over-quarter to $1.84B.

Based on Vanguard National Trust's 13F filing for Q2 2026, filed 13 Aug 2026.